Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 6
Treatment-assignment count: 0
Stratification count: 0
solid tumor basket · Therapy Not Normalized
ROS1 fusion is flagged as trial selection rising because public trials show inclusion required evidence in 10 contexts. FDA CDx context should be reviewed manually.
Strongest role: Inclusion Required
Inclusion-required count: 6
Treatment-assignment count: 0
Stratification count: 0
Threshold count: 2
Common snippets: MSI-H | BRAF V600E
Threshold label: Moderate
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: Medium
Signal count: 0
Recent signals: 0
Density label: Low
https://clinicaltrials.gov/study/NCT03868423 | https://clinicaltrials.gov/study/NCT07259889 | https://clinicaltrials.gov/study/NCT02650401 | https://clinicaltrials.gov/study/NCT06333899 | https://clinicaltrials.gov/study/NCT03155620 | https://clinicaltrials.gov/study/NCT03375437 | https://clinicaltrials.gov/study/NCT04094610 | https://clinicaltrials.gov/study/NCT04671849 | https://clinicaltrials.gov/study/NCT06006793 | https://clinicaltrials.gov/study/NCT02499614